pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    AAVB-039
    Juvenile Macular Degeneration (Stargardt Disease) AAVantgarde Bio Srl
  • Phase 2
    AB-001
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Artbio Inc
  • Phase 2
    AB-002
    Thrombosis Aronora Inc
  • Phase 2
← prev
page 3 of 50
next →
131
Pain89
Neurology1
AB-1003
Limb-Girdle Muscular Dystrophy
Asklepios BioPharmaceutical Inc
  • Phase 2
    AB-1009
    Pompe Disease Asklepios BioPharmaceutical Inc
  • Phase 2
    AB-2100
    Metastatic Renal Cell Carcinoma Arsenal Biosciences Inc
  • Phase 2
    ABBVCLS-628
    Polycystic Kidney Disease Calico Life Sciences LLC
  • Phase 2
    ABI-110
    Polypoidal Choroidal Vasculopathy Avirmax Inc
  • Phase 2
    ABO-101
    Primary Hyperoxaluria Type I Chiesi Farmaceutici SpA
  • Phase 2
    ABP-745
    Gouty Arthritis (Gout) Atom Therapeutics Co Ltd
  • Phase 2
    ABS-201
    Androgenic Alopecia Almirall SA
  • Phase 2
    ABSK-141
    Solid Tumor Abbisko Therapeutics Co Ltd
  • Phase 2
    ACD-440
    Neuropathic Pain (Neuralgia) AlzeCure Pharma AB
  • Phase 2
    ACDN-01
    Juvenile Macular Degeneration (Stargardt Disease) Ascidian Therapeutics Inc
  • Phase 2
    ACE-1831
    Immunoglobulin G4-Related Disease (IgG4-RD) Acepodia Inc
  • Phase 2
    ACI-24060
    Alzheimer's Disease$ACIU AC Immune SA
  • Phase 2
    ACP-01
    Vescell
    Chronic Stable Angina Hemostemix Inc
  • Phase 2
    ACP-017
    Cutaneous Squamous Cell Carcinoma (cSCC) Ascendis Pharma AS
  • Phase 2
    ACT-001
    Pediatric Diffuse Intrinsic Pontine Glioma Accendatech Co Ltd
  • Phase 2
    ACTX-401
    Spinal Muscular Atrophy (SMA) Alcyone Therapeutics Inc
  • Phase 2
    ADCED-01
    Soft Tissue Sarcoma ADCendo ApS
  • Phase 2
    ADG-116
    Solid Tumor$ADAG Adagene Inc.
  • Phase 2
    AFM-24I
    Breast Cancer Affimed GmbH
  • Phase 2
    AFTX-201
    Dilated Cardiomyopathy Affinia Therapeutics Inc
  • Phase 2
    AGA-2115
    Osteogenesis Imperfecta Angitia Biopharmaceuticals Ltd
  • Phase 2
    AGLE-102
    Burns Aegle Therapeutics Corp
  • Phase 2
    AGT-100216
    Charcot-Marie-Tooth Disease Type I A Augustine Therapeutics NV
  • Phase 2
    AGuIX
    Glioblastoma Multiforme (GBM) NH TherAguix SAS
  • Phase 2
    AI-081
    Solid Tumor OncoC4 Inc
  • Phase 2
    AION-301
    Chronic Kidney Disease (Chronic Renal Failure) AION Healthspan Inc